Trevena, Inc. (TRVN)

USD 1.27

(-0.78%)

Revenue Summary of Trevena, Inc.

  • Trevena, Inc.'s latest annual revenue in 2023 was 3.12 Million USD , up 847.61% from previous year.
  • Trevena, Inc.'s latest quarterly revenue in 2024 Q2 was 325 Thousand USD , up 1525.0% from previous quarter.
  • Trevena, Inc. reported a annual revenue of -418 Thousand USD in annual revenue 2022, down -173.72% from previous year.
  • Trevena, Inc. reported a annual revenue of 567 Thousand USD in annual revenue 2021, down -81.52% from previous year.
  • Trevena, Inc. reported a quarterly revenue of 20 Thousand USD for 2024 Q1, up 124.69% from previous quarter.
  • Trevena, Inc. reported a quarterly revenue of 3.02 Million USD for 2023 Q2, up 50250.0% from previous quarter.

Annual Revenue Chart of Trevena, Inc. (2023 - 2011)

Historical Annual Revenue of Trevena, Inc. (2023 - 2011)

Year Revenue Revenue Growth
2023 3.12 Million USD 847.61%
2022 -418 Thousand USD -173.72%
2021 567 Thousand USD -81.52%
2020 3.06 Million USD 9800.0%
2019 31 Thousand USD -99.46%
2018 5.73 Million USD 0.0%
2017 - USD -100.0%
2016 3.75 Million USD -40.0%
2015 6.25 Million USD 0.0%
2014 - USD -100.0%
2013 134.98 Thousand USD -83.29%
2012 807.59 Thousand USD -66.65%
2011 2.42 Million USD 0.0%

Peer Revenue Comparison of Trevena, Inc.

Name Revenue Revenue Difference
America Great Health 204.3 Thousand USD -1429.553%
Ampio Pharmaceuticals, Inc. - USD -Infinity%
Aridis Pharmaceuticals, Inc. - USD -Infinity%
Biora Therapeutics, Inc. 4000.00 USD -78025.0%
Bio-Path Holdings, Inc. - USD -Infinity%
Better Therapeutics, Inc. - USD -Infinity%
Calithera Biosciences, Inc. - USD -Infinity%
Comera Life Sciences Holdings, Inc. 633.1 Thousand USD -393.601%
Gene Biotherapeutics, Inc. - USD -Infinity%
eFFECTOR Therapeutics, Inc. - USD -Infinity%
Eloxx Pharmaceuticals, Inc. - USD -Infinity%
Evelo Biosciences, Inc. - USD -Infinity%
Evolutionary Genomics, Inc. - USD -Infinity%
Finch Therapeutics Group, Inc. 107 Thousand USD -2820.561%
Galera Therapeutics, Inc. - USD -Infinity%
Innovation1 Biotech Inc. - USD -Infinity%
Kiromic BioPharma, Inc. - USD -Infinity%
Molecular Templates, Inc. 57.3 Million USD 94.547%
Navidea Biopharmaceuticals, Inc. 65.65 Thousand USD -4659.946%
NexImmune, Inc. - USD -Infinity%
Orgenesis Inc. 530 Thousand USD -489.623%
Panbela Therapeutics, Inc. - USD -Infinity%
Point of Care Nano-Technology, Inc. - USD -Infinity%
PaxMedica, Inc. Common Stock - USD -Infinity%
Scopus BioPharma Inc. - USD -Infinity%
Sorrento Therapeutics, Inc. 62.83 Million USD 95.027%
Statera Biopharma, Inc. - USD -Infinity%
TRACON Pharmaceuticals, Inc. 12.04 Million USD 74.056%
Vaxxinity, Inc. - USD -Infinity%
Vaccinex, Inc. 570 Thousand USD -448.246%
Vicapsys Life Sciences, Inc. - USD -Infinity%
Viracta Therapeutics, Inc. - USD -Infinity%
ZIVO Bioscience, Inc. 27.65 Thousand USD -11201.989%